Literature DB >> 17131363

Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age.

Pey-Jen Yu1, Giovanni Ferrari, Aubrey C Galloway, Paolo Mignatti, Giuseppe Pintucci.   

Abstract

After over thirty years from its discovery, research on basic fibroblast growth factor (FGF-2) keeps revealing new aspects of the complexity of its gene expression as it evolved in the eukaryotic organisms. The discovery of multiple forms of FGF-2 generated by alternative translation from AUG and non-canonical CUG codons on the same mRNA transcript has led to the characterization of a low molecular weight (LMW) FGF-2 form and various high molecular weight (HMW) forms (four in humans). In this review, we discuss the biochemical features and biological activities of the different FGF-2 forms. In particular, we focus on the properties that are unique to the HMW forms and its biological functions. c 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131363     DOI: 10.1002/jcb.21116

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  41 in total

1.  Endogenously produced FGF2 is essential for the survival and proliferation of cultured mouse spermatogonial stem cells.

Authors:  Yan Zhang; Si Wang; Xiuxia Wang; Shangying Liao; Yujian Wu; Chunsheng Han
Journal:  Cell Res       Date:  2012-01-31       Impact factor: 25.617

2.  Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.

Authors:  Ana Sahores; Virginia Figueroa; María May; Marcos Liguori; Adrián Rubstein; Cynthia Fuentes; Britta M Jacobsen; Andrés Elía; Paola Rojas; Gonzalo R Sequeira; Michelle M Álvarez; Pedro González; Hugo Gass; Stephen Hewitt; Alfredo Molinolo; Claudia Lanari; Caroline A Lamb
Journal:  Horm Cancer       Date:  2018-06-28       Impact factor: 3.869

3.  Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.

Authors:  Kristen Haberthur; Christine Meyer; Nicole Arnold; Flora Engelmann; Daniel R Jeske; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

4.  The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Authors:  Siyun Liao; Janet R Bodmer; Mohamad Azhar; Gilbert Newman; J Douglas Coffin; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2010-01-29       Impact factor: 5.000

5.  Early generalized overgrowth in boys with autism.

Authors:  Katarzyna Chawarska; Daniel Campbell; Lisha Chen; Frederick Shic; Ami Klin; Joseph Chang
Journal:  Arch Gen Psychiatry       Date:  2011-10

6.  Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.

Authors:  Jiefeng Wang; Hongtao Liu; Xiaoyang Liu; Xiaojun Qi
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

8.  Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.

Authors:  Liping Xiao; Takahiro Naganawa; Joseph Lorenzo; Thomas O Carpenter; J Douglas Coffin; Marja M Hurley
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

9.  Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity.

Authors:  P-J Yu; G Ferrari; L Pirelli; A C Galloway; P Mignatti; G Pintucci
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

10.  A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells.

Authors:  Livia Eiselleova; Kamil Matulka; Vitezslav Kriz; Michaela Kunova; Zuzana Schmidtova; Jakub Neradil; Boris Tichy; Dana Dvorakova; Sarka Pospisilova; Ales Hampl; Petr Dvorak
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.